Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
View graph of relations


Oncology; Cancer immune therapy; Sarcoma; Malignant melanoma; Tumor infiltrating lymphocytes

Main research areas

Oncology; Sarcoma; Cancer immune therapy; Tumor infiltrating lymphocytes

Current research

Preclinical development of tumor-infiltrating lymphocytes (TIL) based adoptive cell transfer immunotherapy (ACT) for patients with sarcoma

ACT based on infusion of autologous TILs has the ability to induce complete and durable response in some patients with advanced malignant melanoma. We believe that this approach could also be effective in sarcoma. We are investigating feasibility of expanding TILs from sarcoma specimens, as well as performing functional in vitro analyses on these TILs.

Potential conflicts of interest

No conflicts of interest

ID: 45967375